4Filing Date: Feb 2, 2026

Dexcom (DXCM)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001093557-26-000012
Total Value$194.8K
Trades2
Insiders1

Transaction Details

Stern Sadie
EVP, Chief HR Officer·Direct
Grant · Acquire
Common Stock
Shares+7.12K
Price$0.00
Total Value$0
Shares Owned After112.35K
Transaction DateJan 29, 2026
Footnotes ▸

Represents shares issued to the Reporting Person upon vesting of performance-based restricted stock units (PSUs) granted to the Reporting Person on March 8, 2023, resulting from achievement of performance conditions under the PSUs.

Stern Sadie
EVP, Chief HR Officer·Direct
Tax W/H · Dispose
Common Stock
Shares-2.66K
Price$73.36
Total Value$194.8K
Shares Owned After109.69K
Transaction DateJan 29, 2026
Footnotes ▸

Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale by the Reporting Person. | Included in this number are 74,450 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026.

Post-Transaction Holdings

Stern Sadie · EVP, Chief HR Officer
SecuritySharesChange
Common Stock112.35K+4.47K (4.14%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-01-29 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: DEXCOM INC (DXCM) CIK: 0001093557 --- Reporting Owner --- Name: Stern Sadie CIK: 0001797971 Role: Officer (EVP, Chief HR Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-01-29 | Code: A (Grant or award) Shares: +7,123 | Price: $0.00 Shares Owned After: 112,346 | Ownership: D (Direct) Footnotes: [F1] Represents shares issued to the Reporting Person upon vesting of performance-based restricted stock units (PSUs) granted to the Reporting Person on March 8, 2023, resulting from achievement of performance conditions under the PSUs. [Transaction #2] Security: Common Stock Date: 2026-01-29 | Code: F (Payment of exercise/tax) Shares: -2,656 | Price: $73.36 Total Value: $194,844.16 Shares Owned After: 109,690 | Ownership: D (Direct) Footnotes: [F2] Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale by the Reporting Person. [F3] Included in this number are 74,450 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026. --- Footnotes (Complete Index) --- F1: Represents shares issued to the Reporting Person upon vesting of performance-based restricted stock units (PSUs) granted to the Reporting Person on March 8, 2023, resulting from achievement of performance conditions under the PSUs. F2: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale by the Reporting Person. F3: Included in this number are 74,450 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026. --- Signature --- /s/ /s/ Jereme M. Sylvain, as Attorney-in-Fact for Sadie Stern (2026-02-02)

keid analysis is for reference only and does not constitute investment advice.